As this review aims at primarily discussing the response of monocytes/macrophages to altered IFN levels in the TME independent of the exact source, we will only provide a broad overview of the factors contributing to elevated type I IFN production by both tumor and stromal cells within the TME. The gene discussed is IFNA1; the disease is neoplasm.